Skip to main content

Table 4 Factors associated with purchasing an RDT in the ADDO when the patient was present

From: Expanding access to parasite-based malaria diagnosis through retail drug shops in Tanzania: evidence from a randomized trial and implications for treatment

Outcome: receiving an RDT in an ADDO if present to be tested (n = 464) Bivariable Multivariable
OR 95% CI p value OR 95% CI p value
Intervention
 No subsidy Reference    
 Subsidy 1.1 (0.6–1.9) 0.868    
Customer gender (if not patient)
 Female Reference    
 Male 1.2 (0.5–2.7) 0.654    
Patient gender
 Female Reference    
 Male 1.0 (0.7–1.4) 0.920    
Customer age (if not patient) 1.0 (1.0–1.0) 0.198    
Patient age
 <5 years Reference    
 5− <14 years 1.5 (0.7–3.5) 0.332    
 14+ years 0.7 (0.3–1.3) 0.254    
Customer education
 Primary Reference    
 Secondary and above 1.0 (0.6–1.6) 0.909    
Wealth index
 Lowest Reference    
 Lower 1.0 (0.5–2.0) 0.925    
 Middle 0.9 (0.4–1.8) 0.723    
 Higher 1.2 (0.6–2.5) 0.559    
 Highest 1.0 (0.5–2.2) 0.943    
Has heard of RDTs 3.1 (2.0–4.8) <0.001 1.7 (0.9–3.1) 0.088
Has taken an RDT before 3.1 (2.1–4.7) <0.001 1.9 (1.2–3.0) 0.005
Sought treatment prior to ADDO visit 0.3 (0.2–0.5) <0.001 0.3 (0.2–0.5) <0.001
Knew before coming that testing was available in ADDOs 3.0 (2.0–4.7) <0.001 1.9 (1.1–3.3) 0.032
Believes febrile patients should be blood tested before treating  
 Never Reference    
 Sometimes 1.1 (0.1–8.9) 0.925    
 Always 2.0 (0.3–13.9) 0.474